Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Completed
National Cancer Institute (NCI)
N/A
2003-01-01
RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for
prostate cancer to have an erection for sexual activity and may improve sexual satisfaction
and quality of life.
PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating
erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for
prostate cancer in clinical trial RTOG-9910.
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Completed
Radiation Therapy Oncology Group
N/A
2003-01-01
RATIONALE: Sildenafil may be effective in helping patients who have undergone treatment for
prostate cancer to have an erection for sexual activity and may improve sexual satisfaction
and quality of life.
PURPOSE: Randomized clinical trial to study the effectiveness of sildenafil in treating
erectile dysfunction in patients who have undergone radiation therapy and hormone therapy for
prostate cancer in clinical trial RTOG-9910.
Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer
Completed
National Cancer Institute (NCI)
Phase 2
2001-08-01
RATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard
therapies for erectile dysfunction may be effective in helping patients with prostate cancer
improve sexual satisfaction and quality of life. It is not yet known whether erectile
dysfunction therapy and nerve-sparing prostatectomy are more effective with or without nerve
grafting.
PURPOSE: This randomized phase II trial is studying nerve grafting and standard therapy to
see how well they work compared to standard therapy alone in treating erectile dysfunction in
patients undergoing nerve-sparing radical prostatectomy for localized prostate cancer.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
